ICAP
News & Events Conferences, Events, News

ICAP at AIDS 2026

  • Date: July 24-31, 2026
  • Location: Rio de Janeiro, Brazil

Join ICAP at AIDS 2026! 

ICAP’s global health experts will showcase their research and insights at AIDS 2026, the 26th International AIDS Conference from July 26 through July 31 in Rio de Janeiro, Brazil. ICAP’s presentations will include a satellite session, a workshop, and 25 posters and e-posters investigating fundamental questions around the global HIV response.

ICAP will also be present at the 18th International Workshop on Pediatrics & HIV 2026 held in Rio on July 24-24, where ICAP’s senior research director, Elaine Abrams, MD, will present opening remarks.

ICAP highlights at AIDS 2026 include:

July 28, 14:30 – 16:30 | Workshop: Protecting what works: Sustainable, integrated, key population-sensitive models balancing community-led and facility-based services, with the participation of Cassia Wells, MD, MPH, ICAP’s senior technical advisor and deputy director, technical of the CQUIN network.

July 29, 18:00 – 19:30 | Satellite: Unfinished business: Ending preventable deaths from advanced HIV disease in a changing HIV response, featuring the participation of Maureen Syowai, MBChB, MSc, project director for the CQUIN and HIVE networks.

Abstracts with ICAP Authors

Title Authors Institutions
Awareness of ‘undetectable equals untransmissible’ (U=U) messaging among adults aged ≥15 years in Tanzania: evidence from the Tanzania HIV Impact Survey, 2022-2023 D. Damian1, J. Kitalile1, A. Mbunda1, A. Ismail1, D. Kakiziba2, A. Wang1, E. Kanakoko1, A. Khatib3, O.E. Rwabiyago1, D. Magesa1, S. Nsumba4, S.E. Porter1, R.L. Laws5, G. Mgomella1, J.M. Grund1, M. Swaminathan1, P.F. Njau6, N. Schaad1 1U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania, the United Republic of, 2ICAP at Columbia University, Dar es Salaam, Tanzania, the United Republic of, 3Zanzibar AIDS Commission, Zanzibar, Tanzania, the United Republic of, 4Tanzania Commission for AIDS, Dodoma, Tanzania, the United Republic of, 5U.S. Centers for Disease Control and Prevention, Atlanta, United States, 6National AIDS, STI, and Hepatitis Control Programme, Dodoma, Tanzania, the United Republic of
Strengthening HIV prevention through safe initiation of injectable PrEP: lessons learned from PCR integration in a long-acting cabotegravir (CAB-LA) pilot in Nampula, Mozambique A. Couto1, P. Antonio2, V. Mega2, G. Amane2, I. Gaspar2, H. Macul3, E. Gusmao3, M. Abudou4, S. Xavier5, S. Felix4, D. Uetela6 1Ministry of Health of Mozambique, Public Health Directorate, Maputo, Mozambique, 2Ministry of Health of Mozambique, National STI, HIV and AIDS Control Programme, Maputo, Mozambique, 3University of Columbia, ICAP, Maputo, Mozambique, 4Servico Provincial de Saude Nampula, Nampula, Mozambique, 5Direccao Provincial de Saude de Nampula, Nampula, Mozambique, 6Instituto Nacional de Saude, Maputo, Mozambique
Factors associated with willingness to take pre-exposure prophylaxis among HIV negative breastfeeding women: findings from Tanzania HIV impact survey 2022-2023 B. Msongole1, E. Taluka1, L. Katengesha1, K. Sachathep2, M. Nyamhagatta3, M. Msangi3, J. Zech2, M. Syowai4, R. Fayorsey2, E.J. Abrams2 1ICAP at Columbia University, Dar es Salaam, Tanzania, the United Republic of, 2ICAP at Columbia University, New York, United States, 3Ministry of Health, Dodoma, Tanzania, the United Republic of, 4ICAP at Columbia University, Nairobi, Kenya
The effect of facility-led continuous quality improvement (CQI) projects on HIV services in Cameroon’s Far North region, 2024–2025 G.F. Tayong1,2, P.R. Enokbonong1, J.N. Mbonda1, J.T. Ticha1, C.M. Mirizoukou1, R.A. Fodjo1, F.C. Anyiang1, B.A. Asanga1, M.A. Fomum1, M. Ahamat1, T. Ayukotabe3, E. Lyonga3, K.A. Bosh3, M. Jalloh3, Y.M. Fadil3, L. Eno3, A.S. Dama4, W. Essapo1, E. Morrison5, R. Brigid5, C. Steiner6, N. Justin7, G.L. Ekali1 1ICAP at Columbia University, Yaounde, Cameroon, 2University of Bamenda, Department of Public Health, Faculty of Health Sciences, Bambili, Cameroon, 3Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Yaounde, Cameroon, 4Regional Technical Group for the Fight against HIV, Maroua, Cameroon, 5ICAP at Columbia University, Mailman School of Public Health, New York, United States, 6University of Witwatersrand, Johannesburg, South Africa, 7Division of Health Operational Research, Ministry of Public Health, Yaounde, Cameroon
HIV prevalence disparities among adolescent girls and young women with overlapping risks in eastern and southern Africa: findings from seven Population-based HIV Impact Assessment surveys, 2019–2023 C.J. Heck1, H. Reyes Nieva1, S. Wallach2, K. Ganesan3, D. Quigee2, S. Mitchell2, J. Zucker1, S. Farley4, A. Howard4, J. Justman4, W. El-Sadr4, D. Castor1 1Columbia University Irving Medical Center, Medicine, New York, United States, 2Columbia University Mailman School of Public Health, Epidemiology, New York, United States, 3Independent Researcher, Washington DC, United States, 4ICAP, New York, United States
Who are the men? A partnership-level analysis characterizing male relationships involving adolescent girls and young women: findings from population-based surveys across East and Southern Africa S.L. Mitchell1,2, C.J. Heck3, D. Castor1,3 1Columbia University Mailman School of Public Health, Department of Epidemiology, New York, United States, 2ICAP at Columbia University, New York, United States, 3Columbia University Irving Medical Center, Department of Medicine, Division of Infectious Diseases, New York, United States
Preserving vertical transmission prevention of HIV services in a shifting global health landscape L. Ndapatani1, L. Katengesha2, K. Sachathep3, W. Reidy3, J. Zech3, K. Khosa4, N. Pato5, C. Awuor5, H. Iyanda6, M. Msangi7, C. Phiri8, N. Eliseu9, M. Chanase9, M. Syowai1, R. Farosey3, E. J. Abrams3 1ICAP at Columbia University, Nairobi, Kenya, 2ICAP at Columbia University, Dare Salam, Tanzania, the United Republic of, 3ICAP at Columbia University, New York, United States, 4The National Department of Health, Pretoria, South Africa, 5Ministry of Health, National Aids and STIs Control Program, Nairobi, Kenya, 6Federal Ministry of Health, National AIDS, Viral Hepatitis, and STIs Control Programme, Abuja, Nigeria, 7Ministry of Health, , Directorate of Reproductive, Maternal and Child Health – VTP Unit, Dodoma, Tanzania, the United Republic of, 8Ministry of Health, VTP Unit, Lusaka, Zambia, 9Ministry of Health, VTP unit, Maputo, Mozambique
The Key Population Data Initiative: using individual participant data meta-analysis for granular estimates of HIV prevalence, age, and duration at-risk in sub-Saharan Africa R.L. Anderson1, O. Stevens1, J. Knight1, D. Adjei Annang2, A. Adoko3, S.C. Ahouada4, P. Akilimali Zalagile5,6, S. Allen7, T. Chidarikire8, M.A. Djaló9, M. Dijkstra10, S. Diabaté11,12, A. Diabagate13, C. Adobea Asanté14, M.d.R. Marques15, O.F. Nyamucherera16, S. Farley17, C. Fontaine18, S. Graham19, A. Jahn20,21, E. Karita22, T. Koubagnine23, D.K. Ekouevi24, R. Lako25, J. Larmarange26, S. Luchters27,28,29, F.O. Otieno30, S. Matse31, R.S. McClelland32, C.R.L. Miakassissa Mapapa33, W. Miller34, A. Ndayizeye35, F.L. Nguette Woza36, R. Ntale37, S. Ogoundele4, L. Platt38, B. Richardson39, M. Richter40, K. Sabin41, C. Semá Baltazar42, R. Rigoni43, T.G.M. Sandfort44, A. Scheibe45,46, J.S. Boukaka Kaled47, S. Thiam48, F.B. Tolno49, B. Zanoni50, B. Williams51, E. Gouws52, H. Van Renterghem53, A. Voets54, D.A. Ogbang23, L. Mothae55, J.W. Imai-Eaton1,56 1Imperial College London, MRC Centre for Global Infectious Disease Analysis, London, United Kingdom, 2Ghana AIDS Commission, Accra, Ghana, 3UNAIDS Benin, Cotonou, Benin, 4PLAN International Benin, Cotonou, Benin, 5Kinshasa School of Public Health, University of Kinshasa, Department of Nutrition, Kinshasa, Congo, the Democratic Republic of the, 6Democratic Republic of Congo National Public Health Institute, Kinshasa, Congo, the Democratic Republic of the, 7Emory University, Department of Pathology and Laboratory Medicine, Atlanta, United States, 8World Health Organization South Africa, Pretoria, South Africa, 9ENDA Santé, Dakar, Senegal, 10Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, Netherlands, the, 11Université Laval, Département de médecine sociale et préventive, Faculté de Médecenine, Québec, Canada, 12Centre de Recherche du CHU de Québec-Université Laval, Axe Santé des populations et pratiques optimales en santé, Québec, Canada, 13Programme National de Lutte contre le Sida, Abidjan, Côte d’Ivoire, 14University of Johannesburg, Johannesburg, South Africa, 15Instituto Nacional de Luta Contra a Sida, Luanda, Angola, 16Independent Development Consultant, Harare, Zimbabwe, 17Columbia University, ICAP, New York, United States, 18UNAIDS, Geneva, Switzerland, 19University of Washington, Behavioral Research Center for HIV (BIRCH), Seattle, United States, 20Ministry of Health and Sanitation, Directorate of HIV, STI and Viral Hepatitis, Lilongwe, Malawi, 21Clinton Health Access Initiative, Lilongwe, Malawi, 22Emory University, Rwanda Zambia HIV Research Group (RZHRG), Kigali, Rwanda, 23UNAIDS Nigeria, Abuja, Nigeria, 24Université de Lomé, Faculté des Sciences de la Santé, Lomé, Togo, 25Ministry of Health, Juba, South Sudan, 26Centre Population et Développement, Université Paris Cité, Université Paris Cité, Université Sorbonne Paris Nord, Institut de Recherche pour le Développement, Inserm, Paris, France, 27Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 28Centre for Sexual Health and HIV AIDS Research (CeSHHAR), Harare, Zimbabwe, 29Ghent University, Ghent, Belgium, 30Nyanza Reproductive Health Society, Kisumu, Kenya, 31Eswatini National AIDS Program, Mbabane, Eswatini, 32University of Washington, Departments of Medicine, Epidemiology, and Global Health, Seattle, United States, 33Programme National de Lutte Contre le Sida, Brazzaville, Congo, the, 34Tulane University, Weatherhead School of Public Health and Tropical Medicine, New Orleans, United States, 35Burundi Ministry of Health, Bujumbura, Burundi, 36UNAIDS Country Office for the Central African Republic, Bangui, Central African Republic, the, 37Soroti University, School of Medicine, Arapai, Uganda, 38London School of Hygiene and Tropical Medicine, Faculty of Public Health and Policy, London, United Kingdom, 39University of Washington School of Public Health, Department of Biostatistics, Seattle, United States, 40University of Cape Town, School of Public Health, Cape Town, South Africa, 41UNSW Medicine, National Drug and Alcohol Research Centre, Sydney, Australia, 42National Institute of Health, Maputo, Mozambique, 43Correlation- European Harm Reduction Network, Amsterdam, Netherlands, the, 44Columbia University, New York State Psychiatric Institute, New York, United States, 45TB HIV Care, Cape Town, South Africa, 46University of Pretoria, Community Oriented Primary Care Research Unit, Department of Family Medicine, Pretoria, South Africa, 47Programme National de Lutte contre le Sida (PNLS), Brazzaville, Congo, the, 48National AIDS Council of Senegal, Dakar, Senegal, 49PLAN International Guinea, Conakry, Guinea, 50Emory University, Emory School of Medicine, Atlanta, United States, 51SACEMA, Stellenbosch University, Stellenbosch, South Africa, 52UNAIDS, Data for Impact, Geneva, Switzerland, 53UNAIDS Côte d’Ivoire, Abidjan, Côte d’Ivoire, 54Mainline, Amsterdam, Netherlands, the, 55Ministry of Health and Ministry of Finance and development, Maseru, Lesotho, 56Harvard University, Harvard T H Chan School of Public Health, Boston, United States
Who is dying from AIDS in Brazil: a nationwide analysis of causes of death A.R. Pascom1, E. Fazito2, A. Krummenauer1, N. Veras1, I. Pereira1, T. Benoliel1, A.P. Betaressi1, A. Kalichman1, D. Barreira1 1Ministry of Health of Brazil, HIV/AIDS, TB, VH and STI Department, Brasilia, Brazil, 2ICAP Brazil, Brasilia, Brazil
Prevalence and risk factors associated with Advanced HIV disease among people living with HIV in the Philippines, 2019-2024 J. Bacha1, F. Smith1, A. Zamora2, E. Agyemang1, M. Tejan1, R. Lacson2, J. Yang3, R. Haynes3, N.G. Saplagio3, N. Palaypayon3, N. Montevirgen4, E. Dano4, M.E. Evans2 1U.S. Centers for Disease Control and Prevention, Atlanta, United States, 2U.S. Centers for Disease Control and Prevention, Manila, Philippines, the, 3Philippines Department of Health, Epidemiology Bureau, Manila, Philippines, the, 4ICAP, Columbia University, Manila, Philippines, the
Oral PrEP adherence among male clients of female sex workers in Kisumu, Kenya S. Wallach1,2, M.R. Lamb1, J. Franks2, A. Zerbe2, D. Reed3, J.E. Mantell4, J. Moraa5, D. Omollo5, L. Wiesner6, D. Naitore2, W.M. El-Sadr2 1Columbia University, Department of Epidemiology, New York, United States, 2ICAP at Columbia University, New York, United States, 3Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, United States, 4Columbia University Irving Medical Center, Department of Psychiatry, New York, United States, 5Impact Research and Development Organization, Kisumu, Kenya, 6Division of Clinical Pharmacology, University of Cape Town, Department of Clinical Psychology, Cape Town, South Africa
Assessing system readiness for vertical transmission elimination: capability maturity findings from six Sub-Saharan African countries L. Nazi1, L. Katengesha2, K. Sachathep3, W. Reidy3, J. Zech3, K. Khosa4, N. Pato5, C. Awuor5, H. Iyanda6, M. Msangi7, C. Phiri8, N. Eliseu9, M. Chanase9, M. Syowai1, R. Farosey3, E. J. Abrams3 1ICAP at Columbia University, Nairobi, Kenya, 2ICAP at Columbia University, Dare Salam, Tanzania, the United Republic of, 3ICAP at Columbia University, New York, United States, 4The National Department of Health, Pretoria, South Africa, 5Ministry of Health, National Aids and STIs Control Program, Nairobi, Kenya, 6Federal Ministry of Health, National AIDS, Viral Hepatitis, and STIs Control Programme, Abuja, Nigeria, 7Ministry of Health, Directorate of Reproductive, Maternal and Child Health – VTP Unit, Dodoma, Tanzania, the United Republic of, 8Ministry of Health, VTP Unit, Lusaka, Zambia, 9Ministry of Health, VTP Unit, Maputo, Mozambique
What did we learn from the most recent funding cuts: Eswatini experience C. Ngcamphalala1, Y.-R. Yeo1, M. Jeetoo1, D. Charles1, Z. Tfwala2, S. Simelane2, T. Sithole3, N. Mahlalela3, L. Dube3, M. Motsa4, R. Sahabo2, H. Nuwagaba-Biribonwoha5,2, R.S. Braithwaite1 1New York University, Grossman School of Medicine, Population Health, New York, United States, 2ICAP at Columbia University, Mailman School of Public Health, Mbabane, Eswatini, 3Ministry of Health, Mbabane, Eswatini, 4National Emergency Response Council on HIV and AIDS (NERCHA), Mbabane, Eswatini, 5Columbia University, Mailman School of Public Health, Department of Epidemiology, Mailman School of Public Health, New York, United States
Pre-exposure prophylaxis and risk behaviors among adults who tested HIV-negative in Tanzania: insights from the Tanzania HIV impact survey, 2022–2023 A. Kailembo1, N. Nyagonde1, A. Ismail1, T. John1, A. Wang1, G. Mchau1, O. Rwabiyago1, J. Grund1, G. Mgomella1, M. Swaminathan1, T. Nkumbula2, D. Kakiziba2, A. Khatib3, S. Sumba4, S. Porter1 1U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania, the United Republic of, 2ICAP at Columbia University, Dar es Salaam, Tanzania, the United Republic of, 3Zanzibar AIDS Commission, Zanzibar, Tanzania, the United Republic of, 4Tanzania Commission for AIDS, Dodoma, Tanzania, the United Republic of
HIV testing uptake and barriers among high-risk population in Rwanda: a multisite cross-sectional study, 2025 G. N. Rwibasira1,2,3, E. Nkurunziza4, H. Mugisha5, G. Kaberuka4, S. Karera6, J.C. Kwizera7, E. Turatsinze5, D. Rutasingwa5, A. Favina5, E. Mathebula8,9, A. Kagaba5, D. Mutambuka10, S. Semafara11 1Rwanda Biomedical Centre, Kigali, Rwanda, 2Swiss Tropical and Public Health Institute, Allschwil, Basel, Switzerland, Basel, Switzerland, 3University of Basel, Basel, Switzerland, 4University of Rwanda, Kigali, Rwanda, 5Health Development Initiative, Kigali, Rwanda, 6ICAP Global Health, Rwanda Country Office, Kigali, Rwanda, 7Rwanda Biomedical Center/ Ministry of Health, Kigali, Rwanda, 8Abbott Rapid Diagnostics, Johannesburg, Gauteng, South Africa, 9School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa, 10Rwanda Network of People Living with HIV, Kigali, Rwanda, 11Partners in Health – Rwanda, Kigali, Rwanda
Risk and associated factors of HIV vertical transmission among pregnant and breastfeeding women aged 15-49 years: insights from population-based HIV impact assessment surveys across six African countries (2019–2023) A. Ismail1, A. Wang1, F.L. Ussery2, R.L. Laws2, T.W. John1, A. Kailembo1, G. Mchau1, L. Fidelis1, P. Rwehumbiza1, L.S. Shija1, J.M. Grund1, G.S. Mgomella1, M. Swaminathan1, A.C. Voetsch2, D. Kakiziba3, E. Fazito4, W. El-Sadr4, S.E. Porter1 1Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania, the United Republic of, 2Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Atlanta, United States, 3ICAP at Columbia University, Dar es Salaam, Tanzania, the United Republic of, 4ICAP at Columbia University, New York, United States
Data quality assessment of HIV client registers versus pharmacy dispensation records to inform strategic decision making in Cameroon, 2024 L.C. Keleko Gueatia1, F. Djouma1, K.A. Bosh1, J. Fokam2, Y. Moussa Fadil1, S. Lekeumo3, R.P. Enokbonong4, E. Nshom5, I. Fotso6, J. Ndimumeh7, P. Tchendjou3, W. Kum5, F. Kandel Tebong6, W. Nkamji Tchakounteh7, G. Loni Ekali4, A. Sciarratta Boyer8, T. Mariama8, A. Oladipo8, M. Swanson8, S. Ghosh8, M.F. Jalloh1 1Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Yaounde, Cameroon, 2National AIDS Control Committee, Cameroon Ministry of Public Health, Yaounde, Cameroon, 3Elizabeth Glaser Pediatric AIDS Foundation, Yaounde, Cameroon, 4ICAP at Columbia University, Yaounde, Cameroon, 5Cameroon Baptist Convention Health Board, Bamenda, Cameroon, 6SHWARI Health Association, Yaounde, Cameroon, 7Cameroon Association for Social Marketing, Yaounde, Cameroon, 8Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Atlanta, United States
Adolescent decision-making and adherence to antiretroviral therapy in Mozambique: a qualitative analysis of adolescent narratives through the lens of the Dual Systems Model J. Falcao1,2, R. Zandamela2, E.J. Abrams3,4, N.D. Labhardt1, Y. Yussuf2, A. Couto5, A. Zerbe3, E. Gusmão2, M. Weisser6, J.M. Belus1,7,8 1University of Basel, Department of Clinical Research, Basel, Switzerland, 2ICAP, Maputo, Mozambique, 3ICAP, New York, United States, 4Columbia University, New YorkUnit, United States, 5Ministry of Health, Maputo, Mozambique, 6University of Basel, Basel, Switzerland, 7University of Zurich, Department of Psychology, Zurich, Switzerland, 8University of Zurich, Faculty of Medicine, Zurich, Switzerland
Active case finding to address the gap in access to HIV services among children living with HIV in Rwanda: a combined community and facility-based testing approach, 2024 B. Kwizera1, V. Mugisha1, C. Kamanzi1, S. Karera1, G. N Rwibasira2, B. Ikuzo2, D. Mutambuka3 1ICAP at Columbia University, Mailman School of Public Health, Kigali, Rwanda, 2Rwanda Biomedical Center, Ministry of Health, Kigali, Rwanda, 3Rwanda Network of People Living with HIV (RRP+), Kigali, Rwanda
Support groups for caregivers of adolescents with HIV – a qualitative analysis of caregivers’ experiences in Mozambique J. Falcao1,2, J.M. Belus1,3,4, R. Zandamela2, N. Labhardt1, A. Aleny Couto5, A. Zerbe6, E. Gusmão2, M. Weisser7, E.J. Abrams6,8 1University of Basel, Department of Clinical Research, Basel, Switzerland, 2ICAP, Maputo, Mozambique, 3University of Zurich, Department of Psychology, Zurich, Switzerland, 4University of Zurich, Faculty of Medicine, Zurich, Switzerland, 5Ministry of Health, Maputo, Mozambique, 6ICAP, New York, United States, 7University of Basel, Basel, Switzerland, 8Columbia University, New York, United States
Recency reclassification with CD4 testing in HIV surveillance: data from electronic HIV case management system, the Kyrgyz Republic, 2022-2024 N. Usmanova1, B. Kalmyrzaev1, D. Selenic2, D. Miller2, S. Davis2, B. Sheralieva3, C. Zhumalieva3, U. Sarymsakov3, A. Kenzhekarieva3, K. Momusheva3, L. Yanbukhtina3, U. Chockmorova3, V. Ivakin4, P. Nadol1, R. Bhatia1 1CDC, DGHT, Bishkek, Kyrgyzstan, 2CDC HQ, DGHT, Atlanta, United States, 3Republican Center for Bloodborne Viral Hepatitis and HIV Control, Epidemiology, Bishkek, Kyrgyzstan, 4ICAP Regional, Strategic Information, Almaty, Kyrgyzstan
HIV pre-exposure prophylaxis awareness, willingness to use, and uptake among adolescents and young adults in Tanzania: evidence from two nationally representative surveys, 2022–2024 J. Kitalile1, A. Kailembo1, N.J. Nyagonde1, M. Amuri1, A. Ismail1, S.E. Porter1, D. Kakiziba2, E. Karugendo3, F. Issa4, R. Mbatia5, M. Hassan6, P. Njau7, J.M. Grund1, G.S. Mgomella1, O.E. Rwabiyago1 1U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania, the United Republic of, 2ICAP at Columbia University, Dar es Salaam, Tanzania, the United Republic of, 3National Bureau of Statistics, Dodoma, Tanzania, the United Republic of, 4Office of the Chief Government Statistician, Mjini Magharibi, Tanzania, the United Republic of, 5Tanzania Health Promotion Support, Dar es Salaam, Tanzania, the United Republic of, 6Zanzibar Integrated HIV, Hepatitis, TB and Leprosy Programme, Mjini Magharibi, Tanzania, the United Republic of, 7National AIDS, STI, and Hepatitis Control Programme, Dodoma, Tanzania, the United Republic of
Achieving systematic screening for cryptococcal meningitis in Western Province, Zambia using targeted technical assistance at 42 selected sites – a retrospective descriptive study C. Chitanika1, A. Mutiti1, S. Kunda2, W. Mulasikwanda2, T. Kalenge1, S. Masiku1, C. Mumbwe3, T. Dzinamarira1, F. Mansoor1, S. Michaels-Strasser1 1ICAP at Columbia University, Technical, New York, United States, 2ICAP at Columbia University, Strategic Information, New York, United States, 3Ministry of Health, Western Provincial Health Office, Mongu, Zambia
Impact of GeneXpert network on HIV viral load service delivery in South Sudan: a difference-in-differences analysis M. Farahani1, M. Minga2, H. Worku2, D. Dumba2, I. Duku2, A. Kalisto2, M. Samson2, F. Amaruma2, N. Mahachi2, R.N. Fayorsey1 1Columbia University, ICAP, New York, United States, 2Columbia University, ICAP, New York, South Sudan
Incorporating inequality aversion in cost effectiveness analysis to inform long-acting antiretroviral therapy scale-up in Eswatini C. Ngcamphalala1, Y.-R. Yeo1, M. Jeetoo1, D. Charles1, Z. Tfwala2, S. Simelane2, N. Mahlalela3, T. Sithole3, L. Dube3, M. Motsa4, R. Sahabo2, H. Nuwagaba-Biribonwoha2,5, R.S. Braithwaite1 1New York University, Grossman School of Medicine, Population Health, New York, United States, 2ICAP at Columbia University, Mailman School of Public Health, Mbabane, Eswatini, 3Ministry of Health, Mbabane, Eswatini, 4National Emergency Response Council on HIV and AIDS (NERCHA), Mbabane, Eswatini, 5Columbia University, Mailman School of Public Health, Department of Epidemiology, Mailman School of Public Health, New York, United States

For more details, please view the full AIDS 2026 program.

Related Items